Watch STIM. Know when insiders buy.
One email the day a filing lands. Free.
STIM
Neuronetics, Inc.
2.70
−0.04 −1.28%
USD · close Sep 28
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $206.1MP/E —DIV YIELD —FCF YIELD -5.47%REV TTM $155.1M +39.6%NET INCOME −$30.4MNET DEBT $42.3M52W 1.18 – 3.30SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $41.6M | +9.1% | 51.1% | −$1.5M | −$3.4M | — | -0.05 | −$1M | $417K | −$1.4M | Aug 11 |
| Q1 2026 · Mar 31 | $34.5M | +7.8% | 46.9% | −$9M | −$10.8M | — | -0.16 | −$9.4M | $197K | −$9.6M | May 5 |
| Q4 2025 · Dec 31derived | $41.8M | +85.7% | 52.0% | −$5M | −$7.2M | — | -0.10 | $882K | $216K | $666K | Aug 11 |
| Q3 2025 · Sep 30 | $37.3M | +101.3% | 45.9% | −$7.3M | −$9M | — | -0.13 | −$785K | $114K | −$899K | Nov 4 |
| Q2 2025 · Jun 30 | $38.1M | +131.7% | 46.6% | −$8.1M | −$10.1M | — | -0.15 | −$3.5M | $252K | −$3.8M | Aug 11 |
| Q1 2025 · Mar 31 | $32M | +83.6% | 49.2% | −$11M | −$12.7M | — | -0.21 | −$17M | $219K | −$17.2M | May 5 |
| Q4 2024 · Dec 31derived | $22.5M | +10.7% | 66.2% | −$11.5M | −$12.7M | — | -0.34 | −$8.6M | $89K | −$8.7M | Mar 17 |
| Q3 2024 · Sep 30 | $18.5M | +3.6% | 75.6% | −$7.7M | −$13.3M | — | -0.44 | −$5.4M | $386K | −$5.8M | Nov 4 |
| Q2 2024 · Jun 30 | $16.4M | — | 74.0% | −$8.5M | −$9.8M | — | -0.33 | −$5M | $616K | −$5.6M | Aug 5 |
| Q1 2024 · Mar 31 | $17.4M | — | 75.1% | −$6.9M | −$7.9M | — | -0.27 | −$12M | $375K | −$12.4M | May 6 |
| Q4 2023 · Dec 31derived | $20.3M | — | 77.6% | −$4.4M | −$5.4M | — | -0.18 | $2.1M | $879K | $1.3M | Mar 17 |
| Q3 2023 · Sep 30 | $17.9M | — | 65.8% | −$8.9M | −$9.4M | — | -0.33 | −$10.1M | $552K | −$10.7M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $149.2M | 48.5% | −$31.4M | −$39M | -26.1% | -0.59 | −$20.4M | $801K | −$21.2M | — | — |
| FY2024 · to Dec 31 | $74.9M | 72.3% | −$34.6M | −$43.7M | -58.4% | -1.38 | −$31M | $1.5M | −$32.5M | — | — |
| FY2023 · to Dec 31 | $71.3M | 72.5% | −$30.6M | −$30.2M | -42.3% | -1.05 | −$32M | $2.4M | −$34.4M | — | — |
| FY2022 · to Dec 31 | $65.2M | 76.3% | −$35.1M | −$37.2M | -57.0% | -1.38 | −$30.7M | $3.3M | −$34M | — | — |
| FY2021 · to Dec 31 | $55.3M | 78.9% | −$27.6M | −$31.2M | -56.4% | -1.22 | −$28M | $2.4M | −$30.3M | — | — |
| FY2020 · to Dec 31 | $49.2M | 76.5% | −$22.3M | −$27.5M | -55.7% | -1.46 | −$28.4M | $730K | −$29.1M | — | — |
Every number comes from Neuronetics, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.